Current Beat

Feb | 1 | 2024
Press Release
Remix Therapeutics™ Appoints Dominic Reynolds, Ph.D., as Chief Scientific Officer
Dr. Reynolds brings over two decades of leadership experience building biotech companies transformative platforms and drug discovery and development   Watertown, Mass. (February 1, 2024) – Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease, today announced the appointment of Dominic Reynolds, Ph.D., […]
Filter by: All
Media Contact
Lisette Steele
Verge Scientific Communications

What We've Been Up To